Send PM
Followers 28
Posts 4196
Boards Moderated 0
Alias Born 03/20/2011


Re: None

Friday, 11/18/2022 9:31:34 PM

Friday, November 18, 2022 9:31:34 PM

Post# of 92
On October 24, 2022, GSK provided Immatics with notice of its decision to terminate their collaboration. Initially announced on February 20, 2020, the terms of the agreement included a €45 Million (~$50 Million) upfront payment to Immatics and the potential for additional milestone and royalty payments in return for access to two of Immatics’ TCR-T programs. As communicated to Immatics, GSK’s decision was made unrelated to the programs and the progress achieved in the collaboration to date. The termination will be effective on December 26, 2022.

If you go back to this article here (Oct.25/22), had they included Immatics in the article it would have been more definitively clear that GSK was exiting the TCR-T space, imo. Most likely it didn't fit with their business model.

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMTX News